Keros Therapeutics, Inc. - common stock —— 现金流量表 (NASDAQ:KROS) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -36.89 M-62.15 M-70.06 M-124.51 M-160.87 M107.5 M -57.2 M 投资活动产生的现金 -294 K-1.02 M-1.24 M-2.46 M-1.93 M-1.55 M -1.06 M 融资活动产生的现金 296.04 M28.55 M120.31 M178.96 M391.82 M-378.47 M -380.79 M 自由现金流 -36.89 M-62.15 M-70.06 M-124.51 M-160.87 M105.95 M -58.25 M

新闻

KROS Turns to Next Wave of TGF-Beta Muscle Therapies

KROS Turns to Next Wave of TGF-Beta Muscle Therapies

Should You Buy KROS After Q1 Miss and Takeda Deal Reset?

Should You Buy KROS After Q1 Miss and Takeda Deal Reset?

KROS Stock Guide to Rinvatercept in DMD and ALS for 2026

KROS Stock Guide to Rinvatercept in DMD and ALS for 2026

Keros Q1 Loss Wider Than Expected, Revenues Plunge Year Over Year

Keros Therapeutics, Inc. (KROS) Reports Q1 Loss, Misses Revenue Estimates

Aytu BioPharma, Inc. (AYTU) Reports Q3 Loss, Tops Revenue Estimates

Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Lags Revenue Estimates

KROS 2026 Watchlist: 3 Catalysts That Could Reset Sentiment

KROS Stock: Does the Takeda Deal Lower Dilution Risk in 2026?